Similar to the RevM10 study described above, we also observed a transient increase in the level of gene modified cells in the peripheral blood from ~0.125% to ~0.225% during this period, which did not reach statistical significance.
← all excerpts
Development of hematopoietic stem cell based gene therapy for HIV-1 infection: considerations for proof of concept studies and translation to standard medical practice.
1
—
—